Take patient risk factors and convenience into account when selecting an intravenous immunoglobulin product
Publisher: Adis International
ISSN: 1172-0360
Source: Drugs & Therapy Perspectives, Vol.27, Iss.1, 2011-01, pp. : 23-26
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adverse Effects of Intravenous Immunoglobulin Therapy
Drug Safety, Vol. 21, Iss. 3, 1999-09 ,pp. :